better recovery after physical or mental exertion*
The Cochrane Central Register of Control Trials, Medline, Scopus, and Embase databases were searched for relevant SRMAs published until September 2022
Due o tre sessioni settimanali possono essere un obiettivo ragionevole per molte persone, ma il programma deve essere progressivo e adattato a et, fragilit, cardiopatia, dolore articolare e capacit iniziale
Eligibility for GLP-1 medications is typically based on clinical markers and the presence of metabolic comorbidities
It becomes more common with age, affects women more than men, and is strongly associated with medication use
Patients and healthcare providers should maintain awareness of symptoms that may indicate declining kidney function or acute kidney injury, particularly during the first few months of treatment when gastrointestinal side effects are most pronounced